These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

724 related articles for article (PubMed ID: 31401389)

  • 61. Janus Kinase 2 (JAK2) Dissociates Hepatosteatosis from Hepatocellular Carcinoma in Mice.
    Shi SY; Luk CT; Schroer SA; Kim MJ; Dodington DW; Sivasubramaniyam T; Lin L; Cai EP; Lu SY; Wagner KU; Bazinet RP; Woo M
    J Biol Chem; 2017 Mar; 292(9):3789-3799. PubMed ID: 28100771
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Autophagy and non-alcoholic fatty liver disease.
    Lavallard VJ; Gual P
    Biomed Res Int; 2014; 2014():120179. PubMed ID: 25295245
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prolonged Lipid Accumulation in Cultured Primary Human Hepatocytes Rather Leads to ER Stress than Oxidative Stress.
    Rennert C; Heil T; Schicht G; Stilkerich A; Seidemann L; Kegel-Hübner V; Seehofer D; Damm G
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32993055
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Analysis of Liver Microenvironment during Early Progression of Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in Zebrafish.
    Michael C; Martínez-Navarro FJ; de Oliveira S
    J Vis Exp; 2021 Apr; (170):. PubMed ID: 33871465
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A Scoping Review on Lipocalin-2 and Its Role in Non-Alcoholic Steatohepatitis and Hepatocellular Carcinoma.
    Krizanac M; Mass Sanchez PB; Weiskirchen R; Asimakopoulos A
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33799862
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Mitochondria Matter: Systemic Aspects of Nonalcoholic Fatty Liver Disease (NAFLD) and Diagnostic Assessment of Liver Function by Stable Isotope Dynamic Breath Tests.
    Di Ciaula A; Calamita G; Shanmugam H; Khalil M; Bonfrate L; Wang DQ; Baffy G; Portincasa P
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299321
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Hepatocellular proliferation correlates with inflammatory cell and cytokine changes in a murine model of nonalchoholic fatty liver disease.
    Vansaun MN; Mendonsa AM; Lee Gorden D
    PLoS One; 2013; 8(9):e73054. PubMed ID: 24039859
    [TBL] [Abstract][Full Text] [Related]  

  • 68. NASH, Fibrosis and Hepatocellular Carcinoma: Lipid Synthesis and Glutamine/Acetate Signaling.
    Sunami Y
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32947972
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Long-chain fatty acid activates hepatocytes through CD36 mediated oxidative stress.
    Liu J; Yang P; Zuo G; He S; Tan W; Zhang X; Su C; Zhao L; Wei L; Chen Y; Ruan X; Chen Y
    Lipids Health Dis; 2018 Jul; 17(1):153. PubMed ID: 30016988
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Reactive oxygen species-induced TXNIP drives fructose-mediated hepatic inflammation and lipid accumulation through NLRP3 inflammasome activation.
    Zhang X; Zhang JH; Chen XY; Hu QH; Wang MX; Jin R; Zhang QY; Wang W; Wang R; Kang LL; Li JS; Li M; Pan Y; Huang JJ; Kong LD
    Antioxid Redox Signal; 2015 Apr; 22(10):848-70. PubMed ID: 25602171
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease.
    Valenti L; Pedica F; Colombo M
    Dig Liver Dis; 2022 Feb; 54(2):154-163. PubMed ID: 34294580
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Roles of organelle-specific autophagy in hepatocytes in the development and treatment of non-alcoholic fatty liver disease.
    Zhang Y; Chen Y
    Chin Med J (Engl); 2022 Jul; 135(14):1673-1681. PubMed ID: 35950774
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Hypericin attenuates nonalcoholic fatty liver disease and abnormal lipid metabolism via the PKA-mediated AMPK signaling pathway in vitro and in vivo.
    Liang C; Li Y; Bai M; Huang Y; Yang H; Liu L; Wang S; Yu C; Song Z; Bao Y; Yi J; Sun L; Li Y
    Pharmacol Res; 2020 Mar; 153():104657. PubMed ID: 31982488
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hepatocellular carcinoma in the context of non-alcoholic steatohepatitis (NASH): recent advances in the pathogenic mechanisms.
    Lequoy M; Gigante E; Couty JP; Desbois-Mouthon C
    Horm Mol Biol Clin Investig; 2020 Feb; 41(1):. PubMed ID: 32112699
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Role of caveolin-1 in hepatocellular carcinoma arising from non-alcoholic fatty liver disease.
    Takeda M; Sakaguchi T; Hiraide T; Shibasaki Y; Morita Y; Kikuchi H; Ikegami K; Setou M; Konno H; Takeuchi H
    Cancer Sci; 2018 Aug; 109(8):2401-2411. PubMed ID: 29896915
    [TBL] [Abstract][Full Text] [Related]  

  • 76. HNF4α-Deficient Fatty Liver Provides a Permissive Environment for Sex-Independent Hepatocellular Carcinoma.
    Fekry B; Ribas-Latre A; Baumgartner C; Mohamed AMT; Kolonin MG; Sladek FM; Younes M; Eckel-Mahan KL
    Cancer Res; 2019 Nov; 79(22):5860-5873. PubMed ID: 31575546
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The RNA binding protein human antigen R is a gatekeeper of liver homeostasis.
    Subramanian P; Gargani S; Palladini A; Chatzimike M; Grzybek M; Peitzsch M; Papanastasiou AD; Pyrina I; Ntafis V; Gercken B; Lesche M; Petzold A; Sinha A; Nati M; Thangapandi VR; Kourtzelis I; Andreadou M; Witt A; Dahl A; Burkhardt R; Haase R; Domingues AMJ; Henry I; Zamboni N; Mirtschink P; Chung KJ; Hampe J; Coskun Ü; Kontoyiannis DL; Chavakis T
    Hepatology; 2022 Apr; 75(4):881-897. PubMed ID: 34519101
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis.
    Mohamad B; Shah V; Onyshchenko M; Elshamy M; Aucejo F; Lopez R; Hanouneh IA; Alhaddad R; Alkhouri N
    Hepatol Int; 2016 Jul; 10(4):632-9. PubMed ID: 26558795
    [TBL] [Abstract][Full Text] [Related]  

  • 79. NAFLD Related-HCC: The Relationship with Metabolic Disorders.
    Zhang X
    Adv Exp Med Biol; 2018; 1061():55-62. PubMed ID: 29956206
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation.
    Castaño D; Larequi E; Belza I; Astudillo AM; Martínez-Ansó E; Balsinde J; Argemi J; Aragon T; Moreno-Aliaga MJ; Muntane J; Prieto J; Bustos M
    J Hepatol; 2014 May; 60(5):1017-25. PubMed ID: 24362075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.